Cancer 52 alliance releases ‘State of the Nation’ report on rare and less common cancers
4 Feb. 2025What is Cancer52?
Cancer52 is an alliance of over 115 patient charities that advocate for people with rare and less common cancers in the UK. Their goal is to improve diagnosis, treatment, and support for people affected by these cancers. MDS UK is delighted to represent all those affected by MDS and CMML as active members of the Cancer 52 alliance.
New report on Rare and Less Common Cancers
The alliance released a report on Tuesday, 4th February, World Cancer Day 2025, called 'State of the Nation report on Rare and Less Common Cancers: Learning from patients and partners.'
Key priorities in the report
Key priorities outlined in the report include the need to:
- Reduce deaths by tackling health inequalities,
- Drive earlier diagnosis of rare and less common cancers,
- Create a new national taskforce with patient involvement at its core
The report also draws on insights from Cancer52's patient survey, highlighting the broader impact of rare cancers, the importance of early diagnosis, and patients’ experiences of care and support.
More information
- Find out more about Cancer 52 and the work the the alliance does from the Cancer 52 website